Prothena's (NASDAQ:PRTA) Growing Losses Don't Faze Investors as the Stock Advances 9.0% This Past Week

Simply Wall StOct 31 09:08 ET

Oppenheimer Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $62

Moomoo NewsOct 29 08:33 ET · Ratings

Strength Seen in Prothena (PRTA): Can Its 15.0% Jump Turn Into More Strength?

Zacks Oct 29 03:55 ET

Prothena Up Nearly 17%, on Pace for Largest Percent Increase Since October 2023 -- Data Talk

Dow JonesOct 28 10:45 ET

PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday

BenzingaOct 28 10:14 ET

JMP Securities Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $83

Moomoo NewsOct 28 00:31 ET · Ratings